Aug 23, 2022 9:14am EDT Todos Medical Initiates MonkeyPox Diagnostic Case Studies After Being Approached by 4 Patients, Including 3 Women
Aug 22, 2022 9:40pm EDT Todos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ET
Aug 19, 2022 8:30am EDT Todos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVID
Aug 15, 2022 9:48am EDT Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID
Aug 11, 2022 9:07am EDT Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in Adults
Aug 10, 2022 9:11am EDT Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista Diagnostics
Aug 08, 2022 7:25am EDT Todos Medical Announces First Two Contracts for PCR-based MonkeyPox Testing at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
Aug 05, 2022 1:49pm EDT Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics
Aug 03, 2022 7:52am EDT Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
Aug 01, 2022 9:56am EDT Todos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by Tollovid
